1073 Projecten
  • Missies
  • Soort onderzoek
  • Sector
  • Doel
  • Roadmaps
  • Sleuteltechnologieën
  • Jaar

Controlling the immune system with engineered proteins

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission III: Participating with a disease or disability
  • Fundamental
  • (Bio)pharma
The oligomerization and stability profiles of galectins are modulated to tailor their immunoregulatory effects

Bioprinting pancreas organoids for drug screening

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission III: Participating with a disease or disability
  • Fundamental
  • Medical technology
A novel humanized in vitro model to test gene therapies to treat permanent neonatal diabetes

Probiotics boosting immunity in early life

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission I: Lifestyle and living environment
  • Mission III: Participating with a disease or disability
  • (Bio)pharma
Develop evidence-based probiotics to improve children’s immune system for their better life

Gene correction in an attempt to cure heart disease

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission III: Participating with a disease or disability
  • Fundamental
  • Industrial
Advancing gene editing strategies aimed to cure heart disease into the clinic

Modelling human brain aging and Parkinson's disease

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission I: Lifestyle and living environment
  • Mission III: Participating with a disease or disability
  • Fundamental
The project partners will develop a brain organoid model, which recapitulates both aging and Parkinson’s disease features.

Revolutionizing Liver Cancer Treatment with RN-005

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission I: Lifestyle and living environment
  • Fundamental
  • (Bio)pharma
Discover how RN-005 could revolutionize hepatocellular carcinoma treatment by selectively targeting cellular cholesterol, offering a promising new approach with reduced toxicity and enhanced efficacy.